Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)
Funding Landscape's record of a notice published on Grants.gov.
The NIGMS Institutional Development Awards (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding.
- Status
- Open
- Closes
- May 26, 2029920 days left
- Posted
- August 19, 2026
- Eligibility
- Public universities, Private universities, Nonprofits (non-501c3)All 4 applicant types and requirements
- Issuer
- National Institutes of Health
- Notice number
- PAR-27-054
Funding Landscape alerts
Email me listings like thisClose email options
Email me listings like this
National Institutes of Health
You'll get new grants from National Institutes of Health.
Weekly emails when there are new matches. You may also receive an initial email. Stop any time.
Description
The Centers of Biomedical Research Excellence: Development Phase (COBRE-D) program provides funding to enable institutions in IDeA states to increase their biomedical research capacity in broad scientific areas of strategic importance to them but for which they have limited existing infrastructure or expertise. COBRE-D is intended to support a long-term institutional vision focused on the recruitment and mentoring of early-career investigators by supplementing start-up packages for new hires, the establishment of research facilities, and enhancement of research administration support services. This program serves as an on-ramp for less-resourced institutions to the Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S) program.
Requirements
- Applicant types
- Public and State controlled institutions of higher education, Private institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Eligibility is restricted to institutions that meet the following criteria:Are located in an IDeA-eligible state, commonwealth, or jurisdiction, which are Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming; andAward doctoral degrees in the health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies.
Search open grants and contracts on Funding Landscape
Find similar listings
Similar open listings
- Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2029
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Sep 2029
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2029Up to $250K